{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:09:34Z","timestamp":1774076974774,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T00:00:00Z","timestamp":1378339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s10067-013-2366-4","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T06:12:38Z","timestamp":1378275158000},"page":"1759-1764","source":"Crossref","is-referenced-by-count":25,"title":["Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients"],"prefix":"10.1007","volume":"33","author":[{"given":"Francesco","family":"Ursini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Grembiale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saverio","family":"Naty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Daniela","family":"Grembiale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,5]]},"reference":[{"issue":"9","key":"2366_CR1","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/ard.2008.094946","volume":"68","author":"CT Ritchlin","year":"2009","unstructured":"Ritchlin CT et al (2009) Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 68(9):1387\u20131394","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2366_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11926-012-0260-8","volume":"14","author":"WH Boehncke","year":"2012","unstructured":"Boehncke WH, Boehncke S (2012) Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives. Curr Rheumatol Rep 14(4):343\u2013348","journal-title":"Curr Rheumatol Rep"},{"key":"2366_CR3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3899\/jrheum.120239","volume":"89","author":"R Arumugam","year":"2012","unstructured":"Arumugam R, McHugh NJ (2012) Mortality and causes of death in psoriatic arthritis. J Rheumatol Suppl 89:32\u201335","journal-title":"J Rheumatol Suppl"},{"issue":"8","key":"2366_CR4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","volume":"71","author":"T Jon Love","year":"2012","unstructured":"Jon Love T et al (2012) Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis 71(8):1273\u20131277","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2366_CR5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4103\/0019-5154.87149","volume":"56","author":"M Ghiasi","year":"2011","unstructured":"Ghiasi M et al (2011) Psoriasis and increased prevalence of hypertension and diabetes mellitus. Indian J Dermatol 56(5):533\u2013536","journal-title":"Indian J Dermatol"},{"issue":"8","key":"2366_CR6","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","volume":"53","author":"M Holzer","year":"2012","unstructured":"Holzer M et al (2012) Psoriasis alters HDL composition and cholesterol efflux capacity. J Lipid Res 53(8):1618\u20131624","journal-title":"J Lipid Res"},{"issue":"9","key":"2366_CR7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.24014","volume":"59","author":"LS Tam","year":"2008","unstructured":"Tam LS et al (2008) Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheum 59(9):1322\u20131331","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2366_CR8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archdermatol.2012.1401","volume":"148","author":"RS Azfar","year":"2012","unstructured":"Azfar RS et al (2012) Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis diabetes mellitus and psoriasis. Arch Dermatol 148(9):995\u20131000","journal-title":"Arch Dermatol"},{"issue":"5","key":"2366_CR9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/ken090","volume":"47","author":"LS Tam","year":"2008","unstructured":"Tam LS et al (2008) Cardiovascular risk profile of patients with psoriatic arthritis compared to controls\u2014the role of inflammation. Rheumatology (Oxford) 47(5):718\u2013723","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"2366_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","volume":"72","author":"A Jamnitski","year":"2012","unstructured":"Jamnitski A et al (2012) Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 72(2):211\u2013216","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2366_CR11","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"GM Reaven","year":"1988","unstructured":"Reaven GM (1988) Banting lecture, 1998. Role of insulin resistance in human disease. Diabetes 37(12):1595\u20131607","journal-title":"Diabetes"},{"issue":"13","key":"2366_CR12","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1161\/01.CIR.0000088846.10655.E0","volume":"108","author":"MP Reilly","year":"2003","unstructured":"Reilly MP, Rader DJ (2003) The metabolic syndrome: more than the sum of its parts? Circulation 108(13):1546\u20131551","journal-title":"Circulation"},{"issue":"3","key":"2366_CR13","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237(3):E214\u2013E223","journal-title":"Am J Physiol"},{"issue":"7","key":"2366_CR14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412\u2013419","journal-title":"Diabetologia"},{"issue":"1","key":"2366_CR15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","volume":"157","author":"P Gisondi","year":"2007","unstructured":"Gisondi P et al (2007) Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case\u2013control study. Br J Dermatol 157(1):68\u201373","journal-title":"Br J Dermatol"},{"issue":"4","key":"2366_CR16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archdermatol.2010.370","volume":"147","author":"TJ Love","year":"2011","unstructured":"Love TJ et al (2011) Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003\u20132006. Arch Dermatol 147(4):419\u2013424","journal-title":"Arch Dermatol"},{"issue":"1","key":"2366_CR17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000254482","volume":"220","author":"A Balci","year":"2010","unstructured":"Balci A et al (2010) Increased amount of visceral fat in patients with psoriasis contributes to metabolic syndrome. Dermatology 220(1):32\u201337","journal-title":"Dermatology"},{"issue":"5","key":"2366_CR18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1468-3083.2006.01499.x","volume":"20","author":"S Ucak","year":"2006","unstructured":"Ucak S et al (2006) Comparison of various insulin sensitivity indices in psoriatic patients and their relationship with type of psoriasis. J Eur Acad Dermatol Venereol 20(5):517\u2013522","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"2366_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00403-007-0784-3","volume":"299","author":"E Martinez-Abundis","year":"2007","unstructured":"Martinez-Abundis E et al (2007) Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus. Arch Dermatol Res 299(9):461\u2013465","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"2366_CR20","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u20132673","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2366_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/ard.51.2.177","volume":"51","author":"DM Heijde van der","year":"1992","unstructured":"van der Heijde DM et al (1992) Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 51(2):177\u2013181","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2366_CR22","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286\u20132291","journal-title":"J Rheumatol"},{"issue":"12","key":"2366_CR23","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281\u20132285","journal-title":"J Rheumatol"},{"issue":"2","key":"2366_CR24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2337\/diabetes.54.2.333","volume":"54","author":"SE Stern","year":"2005","unstructured":"Stern SE et al (2005) Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 54(2):333\u2013339","journal-title":"Diabetes"},{"key":"2366_CR25","doi-asserted-by":"crossref","unstructured":"Eder L et al (2012) Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Ann Rheum Dis (In Press).","DOI":"10.1136\/annrheumdis-2012-202325"},{"issue":"11","key":"2366_CR26","first-page":"2167","volume":"33","author":"C Han","year":"2006","unstructured":"Han C et al (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33(11):2167\u20132172","journal-title":"J Rheumatol"},{"issue":"4","key":"2366_CR27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00125-012-2462-z","volume":"55","author":"E Hertle","year":"2012","unstructured":"Hertle E, van Greevenbroek MM, Stehouwer CD (2012) Complement C3: an emerging risk factor in cardiometabolic disease. Diabetologia 55(4):881\u2013884","journal-title":"Diabetologia"},{"issue":"5","key":"2366_CR28","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.fertnstert.2011.01.136","volume":"95","author":"S Yang","year":"2011","unstructured":"Yang S et al (2011) Serum complement C3 has a stronger association with insulin resistance than high-sensitivity C-reactive protein in women with polycystic ovary syndrome. Fertil Steril 95(5):1749\u20131753","journal-title":"Fertil Steril"},{"issue":"1","key":"2366_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00011-010-0236-y","volume":"60","author":"B Wang","year":"2011","unstructured":"Wang B et al (2011) Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese. Inflamm Res 60(1):63\u201368","journal-title":"Inflamm Res"},{"issue":"9","key":"2366_CR30","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.2337\/dc07-0637","volume":"30","author":"A Muscari","year":"2007","unstructured":"Muscari A et al (2007) Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population. Diabetes Care 30(9):2362\u20132368","journal-title":"Diabetes Care"},{"issue":"3","key":"2366_CR31","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1172\/JCI116733","volume":"92","author":"A Baldo","year":"1993","unstructured":"Baldo A et al (1993) The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 92(3):1543\u20131547","journal-title":"J Clin Invest"},{"issue":"8","key":"2366_CR32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1365-2362.1999.00514.x","volume":"29","author":"M Maslowska","year":"1999","unstructured":"Maslowska M et al (1999) Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest 29(8):679\u2013686","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"2366_CR33","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1210\/jc.2002-021309","volume":"88","author":"M Faraj","year":"2003","unstructured":"Faraj M et al (2003) Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88(4):1594\u20131602","journal-title":"J Clin Endocrinol Metab"},{"issue":"25","key":"2366_CR34","doi-asserted-by":"crossref","first-page":"23936","DOI":"10.1074\/jbc.M406921200","volume":"280","author":"D Kalant","year":"2005","unstructured":"Kalant D et al (2005) C5L2 is a functional receptor for acylation-stimulating protein. J Biol Chem 280(25):23936\u201323944","journal-title":"J Biol Chem"},{"issue":"32","key":"2366_CR35","doi-asserted-by":"crossref","first-page":"9489","DOI":"10.1021\/bi00198a014","volume":"33","author":"K Cianflone","year":"1994","unstructured":"Cianflone K et al (1994) Adipsin\/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 33(32):9489\u20139495","journal-title":"Biochemistry"},{"issue":"26","key":"2366_CR36","doi-asserted-by":"crossref","first-page":"18243","DOI":"10.1074\/jbc.274.26.18243","volume":"274","author":"V Harmelen Van","year":"1999","unstructured":"Van Harmelen V et al (1999) Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. J Biol Chem 274(26):18243\u201318251","journal-title":"J Biol Chem"},{"issue":"5","key":"2366_CR37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0026-0495(93)90215-A","volume":"42","author":"R Germinario","year":"1993","unstructured":"Germinario R et al (1993) Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. Metabolism 42(5):574\u2013580","journal-title":"Metabolism"},{"key":"2366_CR38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.iy.13.040195.001425","volume":"13","author":"JE Volanakis","year":"1995","unstructured":"Volanakis JE (1995) Transcriptional regulation of complement genes. Annu Rev Immunol 13:277\u2013305","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"2366_CR39","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1046\/j.1365-2362.1997.2090759.x","volume":"27","author":"PW Peake","year":"1997","unstructured":"Peake PW et al (1997) Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes. Eur J Clin Invest 27(11):922\u2013927","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"2366_CR40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/oby.2003.100","volume":"11","author":"BG Gabrielsson","year":"2003","unstructured":"Gabrielsson BG et al (2003) High expression of complement components in omental adipose tissue in obese men. Obes Res 11(6):699\u2013708","journal-title":"Obes Res"},{"issue":"2","key":"2366_CR41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325\u2013331","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2366_CR42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/acr.20363","volume":"63","author":"CC Mok","year":"2011","unstructured":"Mok CC et al (2011) Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res (Hoboken) 63(2):195\u2013202","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"2366_CR43","first-page":"23","volume":"30","author":"MS Chimenti","year":"2012","unstructured":"Chimenti MS et al (2012) Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. Clin Exp Rheumatol 30(1):23\u201330","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2366-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2366-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2366-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T04:35:55Z","timestamp":1563856555000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2366-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,5]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2366"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2366-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,5]]}}}